Development of a halothane-adrenaline arrhythmia model using in vivo guinea pigs

Journal of Pharmacological Sciences

Volumn 95, Issue 2, 2004, Pages 234-239

  Noda, Yoshiaki ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Diltiazem; Halothane adrenaline arrhythmia model; In vivo guinea pig; Nifekalant; Ventricular arrhythmia

Indexed keywords

ADRENALIN; ANTIARRHYTHMIC AGENT; DILTIAZEM; HALOTHANE; NIFEKALANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; GUINEA PIG; HEART VENTRICLE ARRHYTHMIA; MALE; NONHUMAN; VAGOTOMY;

EID: 3142630084     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FP0030423     Document Type: Article

References (23)

1. Hashimoto K, Xue YX, Chen JG, et al. Effects of class III antiarrhythmic drugs on ventricular arrhythmias in dogs. Exp Clin Cardiol. 1997;2:25-29.
2. Luisada AA, Sakai A, Feigen L. Comparative Electrocardiography and phonocardiography in six species of animals. Am J Vet Res. 1970;31:1695-1702.
3. Peterssen EN. Experimental anti-arrhythmic properties of melperone, a neuroleptic butyrophenone. Acta Pharmacol Toxicol. 1978;42:388-394.
4. Scott NC, French AM. The effect of a benzotriazinium salt on in vitro and in vivo arrhythmias in guinea-pigs and mice. Arch Int Pharmacodyn Ther. 1980;248:154-165.
5. Yamada K, Shimamura T, Nakajima H. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions. Jpn J Pharmacol. 1973;23:321-328.
6. Levy G. The genesis of ventricular extrasystoles under chloroform with special references to consecutive ventricular fibillation. Heart. 1914;5:299-334.
7. Hashimoto K, Hashimoto K. The mechanism of sensitization of the ventricle to epinephrine by halothane. Am Heart J. 1972;83:652-658.
8. Zuckerman RL, Wheeler DM. Effect of halothane on arrhythmogenic responses induced by sympathomimetic agents in single rat heart cells. Anesth Analg. 1991;72:596-603.
9. Maze M, Smith CM. Identification of receptor mechanism mediating epinephrine induced arrhythmias during halothane anesthesia in the dog. Anesthesiology. 1983;59:322-326.
10. Hayashi Y, Sumikawa K, Kuro M, et al. Roles of beta-1 and beta-2 adrenoceptors in the mechanisms of halothane myocardial sensitization in dogs. Anesth Analg. 1991;72:435-439.
11. Zhang S, Todoroki S, Urechino H, et al. Role of potassium channels in halothane-epinephrine arrhythmias. Res Commun Mol Pathol Pharmacol. 1998;100:339-350.
12. Rajani V, Hussain Y, Bolla BS, et al. Attenuation of epinephrine-induced dysrhythmias by bradykinin: role of nitric oxide and prostaglandins. Am J Cardiol. 1997;80:153A-157A.
13. Tripathi RM, Thomas GP. A simple method for the production of ventricular tachycardia in the rat and guinea pig. J Pharmacol Methods. 1986;15:279-282.
14. Hoffman P, Muller S, Zbinden G. Decrease of epinephrine-induced arrhythmia threshold in ethanol exposed rats. Arch Toxicol. 1992;66:430-434.
15. Igic R. Mechanism of epinephrine-induced dysrhythmias in rat involves local cholinergic activation. Can J Physiol Pharmacol. 1996;74:85-88.
16. Matsubara I, Hashimoto K, Katano Y, et al. Experimental anti-arrhythmic effects of dl-1-(tert.butylamono)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride(dl Ko 1400-Cl), a new beta-adrenergic receptor blocking agent. Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi). 1976;72:557-571. (text in Japanese with English abstract)
17. Gaynor JS, Bednarski RM, Muir WW 3rd. Effect of hypercapnia on the arrhythmogenic dose of epinephrine in horses anesthetized with guaifenesin, thiamylal sodium, and halothane. Am J Vet Res. 1993;54:315-321.
18. James RG, Arnold JM, Allen JD, et al. The effects of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation. Circulation. 1977;55:311-317.
19. Zuanetti G, De Ferrari GM, Priori SG, et al. Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res. 1987;61:429-435.
20. Zink J, Sasyniuk BI, Dresel PE. Halothane-epinephrine-induced cardiac arrhythmias and the role of heart rate. Anesthesiology. 1975;43:548-555.
21. Iwatsuki N, Katoh M, Ono K, et al. Antiarrhythmic effect of diltiazem during halothane anesthesia in dogs and humans. Anesth Analg. 1985;64:964-970.
22. Komori S, Ishii M, Hashimoto K. Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models. Jpn J Pharmacol. 1985;38:73-82.
23. Xue YX, Yamada C, Aye NN, Hashimoto K. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias. Br J Pharmacol. 1998;124:1712-1718.